BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11782567)

  • 1. Helicobacter pylori, NSAIDs and gastrointestinal haemorrhage.
    Chan FK
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):1-3. PubMed ID: 11782567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.
    Aalykke C; Lauritsen JM; Hallas J; Reinholdt S; Krogfelt K; Lauritsen K
    Gastroenterology; 1999 Jun; 116(6):1305-9. PubMed ID: 10348813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
    Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ
    N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: the effect of Helicobacter pylori infection on nonsteroidal anti-inflammatory drug-induced upper gastrointestinal tract injury.
    Laine L
    Aliment Pharmacol Ther; 2002 Mar; 16 Suppl 1():34-9. PubMed ID: 11849126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori and nonsteroidal anti-inflammatory drugs.
    Chan FK
    Gastroenterol Clin North Am; 2001 Dec; 30(4):937-52. PubMed ID: 11764536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
    Iwamoto J; Saito Y; Honda A; Matsuzaki Y
    World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H. pylori and risk of ulcer bleeding among users of NSAIDS.
    Atherton JC; Wight NJ
    Gastroenterology; 2000 Feb; 118(2):451-2. PubMed ID: 10691374
    [No Abstract]   [Full Text] [Related]  

  • 9. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing.
    Hunt RH; Bazzoli F
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():9-16. PubMed ID: 14725573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F; De Luca L; Graham DY
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management.
    Chan FK
    Drug Saf; 2005; 28(4):287-300. PubMed ID: 15783239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in patients with bleeding from upper part of the gastrointestinal tract].
    Golubović G; Tomasević R; Radojević B; Pavlović A; Dugalić P
    Vojnosanit Pregl; 2007 Jul; 64(7):445-8. PubMed ID: 17821917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
    Ji KY; Hu FL
    World J Gastroenterol; 2006 Jun; 12(24):3789-92. PubMed ID: 16804960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chan FK
    Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
    Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case-control study.
    Okan A; Tankurt E; Aslan BU; Akpinar H; Simsek I; Gonen O
    J Gastroenterol Hepatol; 2003 Jan; 18(1):18-25. PubMed ID: 12519219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of Helicobacter pylori infection on the risk of gastro-duodenal ulcer in patients treated with nonsteroidal antiinflammatory drugs].
    Thiéfin G; Jolly D
    Gastroenterol Clin Biol; 2004 Apr; 28 Spec No 3():C45-57. PubMed ID: 15366674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of Helicobacter pylori infection and use of NSAIDs in the etiopathogenesis of upper gastrointestinal bleeding].
    Sokić-Milutinović A; Krstić M; Popović D; Mijalković N; Djuranović S; Culafić Dj
    Acta Chir Iugosl; 2007; 54(1):51-62. PubMed ID: 17633863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.